← Back to Search

Regional Anesthesia

B group for Analgesia

Phase 4
Waitlist Available
Led By Olga Pewelek, MD
Research Sponsored by The University of Texas Health Science Center, Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up upto 48 hours after procedure
Awards & highlights

Study Summary

This trial is testing whether truncal blocks are effective and safe for pacemaker and AICD implantation in children, and whether they decrease the amount of narcotic medications needed.

Eligible Conditions
  • Analgesia
  • ICD Implantation

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~upto 48 hours after procedure
This trial's timeline: 3 weeks for screening, Varies for treatment, and upto 48 hours after procedure for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
total narcotic dose in milligram morphine equivalents (MME) needed
Secondary outcome measures
Number of patients with incidence of pneumothorax
Number of patients with local anesthetic toxicity
Number of patients with respiratory depression
+3 more

Trial Design

2Treatment groups
Active Control
Group I: B groupActive Control1 Intervention
Group II: Local Anesthetic (LA Group)Active Control1 Intervention

Find a Location

Who is running the clinical trial?

The University of Texas Health Science Center, HoustonLead Sponsor
912 Previous Clinical Trials
323,692 Total Patients Enrolled
1 Trials studying Analgesia
50 Patients Enrolled for Analgesia
Olga Pewelek, MDPrincipal InvestigatorThe University of Texas Health Science Center, Houston
~7 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top